Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Microenvironment Modulation (TME Modulation)
- Target
- TME Modulation
- Molecular classification
- Umbrella Term, Cellular Interaction Network
01
Overview
Tumor microenvironment (TME) modulation refers to therapeutic strategies aimed at altering the complex ecosystem surrounding a tumor to improve cancer treatment outcomes. The TME consists of cancer cells, stromal tissue (including blood vessels, immune cells, fibroblasts), signaling molecules, and the extracellular matrix (ECM). This environment supports tumor growth and invasion and is a major contributor to resistance against current therapies. TME modulation is not a single molecular target but an umbrella term encompassing diverse strategies aimed at reprogramming cellular/molecular interactions around tumors. These interventions seek to disrupt pro-tumoral signals while enhancing anti-tumoral immunity—ultimately improving patient outcomes across multiple cancer types.
- Other names
- TME RemodelingTumor Microenvironment Targeting
02
Mechanism of action
Multiple mechanisms, including: - Immune cell reprogramming - Cytokine/chemokine axis targeting - ECM remodeling - Vascular normalization
03
Biological functions
Regulation of Tumor GrowthImmune ModulationAngiogenesisExtracellular Matrix RemodelingMetastasis
04
Disease associations
Cancer
05
Safety considerations
Off-target effectsCytokine release syndromeImmune-related adverse eventsUnintended consequences of ECM remodelingVascular abnormalities
06
Interacting drugs
Small molecule inhibitors
7 more in the full profile.
07
Biomarkers
Immune cell markers (e.g., PD-L1 expression)Cytokine levels (e.g., IL-6, IL-10)Chemokine levels (e.g., CCL2, CXCL12)ECM components (e.g., Collagen I, Fibronectin)Vascular markers (e.g., VEGF)
Beyond the preview
Go deeper on Tumor Microenvironment Modulation (TME Modulation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Microenvironment Modulation (TME Modulation).